| Category | Antibody |
| Concentration | pH7, with 0, 02% sodium azide, 3, 5 mg/ml in 1X TBS, 5% BSA (US sourced) and 0 |
| Form | Antigen affinity purified |
| Conjugation | Unconjugated |
| Clone | Polyclonal antibody |
| Recognised antigen | APOC1 |
| Host animal | Goat (Capra aegagrus hircus) |
| Clonality | Polyclonal (goat origin) |
| Species reactivity | Due to limited knowledge and inability to test the antibody against all known species, we cannot guarantee that no other cross reactivity can occur, Human (Homo sapiens) |
| Tested applications | ELISA (peptide), IHC |
| Recommended dilutions | ELISA (peptide) LOD: 1:8000, Immunohistochemistry (FFPE): 3-5ug/ml |
| Notes | Optimal dilution of the APOC1 antibody should be determined by the researcher |
| Intented use | This APOC1 antibodyis to be used only for research purposes and not for diagnostics |
| Gene ID # | 341 |
| Purity | Antigen affinity |
| Description | Additional name(s) for this target protein: Apolipoprotein C-I |
| Immunogen | Amino acids ETFQKVKEKLKIDS were used as the immunogen for this APOC1 antibody |
| Storage | Celcius or lower, Cycles of freezing and thawing can denaturate the peptide chains of the antibodies and reduce their sensitivity and/or change their affinity, Prepare aliqotes in such a manner so that freeze-thaw cycles are minimized, Aliquot and store the APOC1 antibody at -20 deg |
| Properties | C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by NJS poly they should be stored frozen at - 24° |
| Gene target | APOC1 |
| Short name | APOC1 Antibody |
| Technique | antibodies against human proteins, antibodies for, Antibody |
| Alternative name | apolipoprotein C-I (Antibody to) |
| Alternative technique | antibodies |
| Alternative to gene target | APOC1 and IDBG-56839 and ENSG00000130208 and 341, Apoc1 and IDBG-152061 and ENSMUSG00000040564 and 11812, Extracellular, phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0004859 and phospholipase inhibitor activity and molecular function this GO :0005504 and fatty acid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005783 and endoplasmic reticulum and cellular component this GO :0006629 and lipid metabolic process and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0008203 and cholesterol metabolic process and biological process this GO :0010873 and positive regulation of cholesterol esterification and biological process this GO :0010900 and negative regulation of phosphatidylcholine catabolic process and biological process this GO :0010916 and negative regulation of very-low-density lipoprotein particle clearance and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0032374 and regulation of cholesterol transport and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034369 and plasma lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034379 and very-low-density lipoprotein particle assembly and biological process this GO :0034382 and chylomicron remnant clearance and biological process this GO :0034447 and very-low-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042627 and chylomicron and cellular component this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0045717 and negative regulation of fatty acid biosynthetic process and biological process this GO :0045833 and negative regulation of lipid metabolic process and biological process this GO :0048261 and negative regulation of receptor-mediated endocytosis and biological process this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0051005 and negative regulation of lipoprotein lipase activity and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060228 and phosphatidylcholine-sterol O-acyltransferase activator activity and molecular function this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0004859: phospholipase inhibitor activity, this GO :0004859: phospholipase inhibitor activity and also this GO :0005504: fatty acid binding and also this GO :0031210: phosphatidylcholine binding and also this GO :0055102: lipase inhibitor activity and also this GO :0060228: phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0005504: fatty acid binding, this GO :0031210: phosphatidylcholine binding, this GO :0055102: lipase inhibitor activity, this GO :0060228: phosphatidylcholine-sterol O-acyltransferase activator activity, apolipoprotein C-I |
| Identity | 607 |
| Gene | APOC1 |
| Long gene name | apolipoprotein C1 |
| Synonyms gene name | apolipoprotein C-I |
| Locus | 19q13, 32 |
| Discovery year | 2001-06-22 |
| GenBank acession | X00570 |
| Entrez gene record | 341 |
| Classification | Apolipoproteins |
| Havana BLAST/BLAT | OTTHUMG00000180844 |
Technique
Supplier
Species
Label
Iso Type
Host
Tissue